Thursday, 5 November 2026European Markets

FINATIS Stock Is 27% Down In The Last 21 Sessions

Loading stream...

finatis societe anonyme, a food distribution company based in france, recently experienced an unprecedented decline in their stock value. over the course of 21 trading sessions, their shares suffered a 27.36% drop, plummeting from eur4.02 per share to eur2.92. this steep drop can be attributed to a streak of five consecutive losing trading sessions.

impact of cac 40 index drop on finatis stock

alongside the fall of finatis shares, the cac 40 index, a benchmark french stock market index, experienced a drop of 0.69%. given that the cac 40 represents the 40 most significant values among the top 100 largest market caps on euronext paris, this decrease suggests a declining market health which could indirectly affect finatis' stock.

overview of finatis operations

operating across france and latin america, finatis provides asset management services and oversees food distribution. its portfolio includes well-known grocery chains such as monoprix, franprix, and casino supermarkets. additionally, to diversify their reach, they manage a private equity portfolio.

finatis' financial performance

recently, finatis' financial performance has been far from impressive. its trailing twelve-month earnings per share (eps) was reported at eur -24.26, which could partially explain the considerable drop in share prices. the troubling financial performance certainly raises concerns for investors and stakeholders.

surge in finatis' trading volume

amid these stock fluctuations, its trading volume has also noticed a significant surge. the reported volume was 752 today, a remarkable 123% increase over its usual level of 113. this surge could represent increased investor interest in the stock, potentially explaining its recent price drop. however, without further information, it becomes challenging to conclusively identify why there has been such an explosion in trading volume.

in light of these uncertainties, it becomes crucial for investors and traders to remain cautiously vigilant when dealing with finatis' shares, keeping a close eye on any developments in its performance.

more news about finatis (fnts.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,549 source documents archived
Query this data → isubstrate.com